Liven Pharma Limited (PSX:LIVEN)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
40.10
+1.37 (3.54%)
At close: Jun 24, 2026

Liven Pharma Ratios and Metrics

Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
4,5336,042110185152303
Market Cap Growth
-18.85%5370.54%-40.46%21.91%-49.80%127.48%
Enterprise Value
4,3816,080349423387535
Last Close Price
40.1055.177.7413.0010.6621.24
PE Ratio
--2.65---
PS Ratio
45.7447.470.45---
PB Ratio
5.479.530.15-1.51-1.38-3.16
P/TBV Ratio
5.539.660.15---
P/FCF Ratio
24.54-8.00---
P/OCF Ratio
20.90-8.00---
EV/Sales Ratio
44.2147.771.42---
EV/EBITDA Ratio
--5.37---
EV/EBIT Ratio
--8.35---
EV/FCF Ratio
23.72-25.26---
Debt / Equity Ratio
0.030.060.21-1.94-2.13-2.43
Debt / EBITDA Ratio
--2.35---
Debt / FCF Ratio
0.15-11.37---
Net Debt / Equity Ratio
-0.180.040.18-1.94-2.13-2.43
Net Debt / EBITDA Ratio
0.30-0.062.03-111.87-79.65-110.82
Net Debt / FCF Ratio
-0.82-1.099.56-104.83-104.11-34.31
Asset Turnover
0.100.140.46---
Inventory Turnover
0.700.90----
Quick Ratio
2.270.190.71000
Current Ratio
3.791.641.48000.00
Return on Equity (ROE)
-81.35%-84.49%13.31%---
Return on Assets (ROA)
-33.95%-35.12%4.93%-6.89%-7.20%-6.80%
Return on Capital Employed (ROCE)
-59.00%-67.10%5.60%14.20%19.10%24.50%
Earnings Yield
-15.47%-9.67%37.80%-6.65%-9.39%-4.83%
FCF Yield
4.08%-0.41%12.50%-1.22%-1.49%-2.24%
Buyback Yield / Dilution
-172.01%-174375.69%99.67%---